Leiomyosarcoma has emerging NIH research funding with 2 grants totaling $9.0M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Leiomyosarcoma. Strongest funded area: Epidemiology / Natural History. Largest gap: Basic Science.
6 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for leiomyosarcoma. Existing research activity suggests this may be a viable area for grant applications.
17 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for leiomyosarcoma. Existing research activity suggests this may be a viable area for grant applications.
20 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for leiomyosarcoma. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Leiomyosarcoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Leiomyosarcoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.